Abstract | INTRODUCTION: METHODS: In vitro autoradiographic studies were carried out with [125 I] IMPY on brain sections from scrapie-infected mice and age-matched controls. Competition study was performed to evaluate the prion deposit binding specificity with nonradioactive IMPY. RESULTS: Binding of [125 I] IMPY was observed in infected brain sections, while on age-matched control brain sections, there was no or very low labeling. Prion deposit binding was confirmed by histoblots with prion protein-specific monoclonal antibody 2D6. In the presence of nonradioactive IMPY, the binding of [125 I] IMPY was significantly inhibited in all regions studied. CONCLUSIONS: These findings indicate that IMPY can detect the prion deposits in vitro in scrapie-infected mice. Labeled with 123 I, this ligand may be useful to quantitate prion deposit burdens in TSEs by in vivo imaging.
|
Authors | Pu-Jiao Song, Serge Bernard, Pierre Sarradin, Jackie Vergote, Céline Barc, Sylvie Chalon, Mei-Ping Kung, Hank F Kung, Denis Guilloteau |
Journal | Nuclear medicine and biology
(Nucl Med Biol)
Vol. 35
Issue 2
Pg. 197-201
(Feb 2008)
ISSN: 0969-8051 [Print] United States |
PMID | 18312829
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid beta-Peptides
- Antibodies, Monoclonal
- Iodine Radioisotopes
- Prions
- Pyrazoles
- Radiopharmaceuticals
- 2,3-dihydro-1H-imidazo(1,2-b)pyrazole
|
Topics |
- Alzheimer Disease
(diagnostic imaging, pathology)
- Amyloid beta-Peptides
(chemistry)
- Animals
- Antibodies, Monoclonal
(chemistry)
- Autoradiography
- Binding, Competitive
- Brain
(diagnostic imaging, pathology)
- Disease Models, Animal
- Humans
- Iodine Radioisotopes
(pharmacokinetics)
- Isotope Labeling
(methods)
- Mice
- Plaque, Amyloid
(diagnostic imaging, pathology)
- Prions
(chemistry)
- Pyrazoles
(pharmacokinetics)
- Radionuclide Imaging
- Radiopharmaceuticals
(pharmacokinetics)
- Scrapie
(diagnostic imaging, pathology)
|